Randomized phase II study of cisplatin and 5-FU continuous infusion (PF) versus cisplatin, UFT and vinorelbine (UFTVP) as induction chemotherapy in locally advanced squamous cell head and neck cancer (LA-SCHNC)

Cancer Chemotherapy and Pharmacology

Volumn 62, Issue 2, 2008, Pages 253-261

  Rivera, Fernando ^a   Vega Villegas, M Eugenia ^a   López Brea, Marta ^a   Isla, Dolores ^b   Mayorga, Marta ^a   Galdós, Piedad ^a   Rubio, Antonio ^a   Del Valle, Adolfo ^a   García Reija, Fe ^a   García Montesinos, Belen ^a   Rodríguez Iglesias, Julio ^a   Mayordomo, Jose ^b   Rama, Julio ^a   Saiz Bustillo, Ramón ^a   Sanz Ortiz, Jaime ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^b Hospital Gonzalo Blesa   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOCETAXEL; FLUOROURACIL; IRON; NAVELBINE; RECOMBINANT ERYTHROPOIETIN; UFT;

ADULT; AGED; ALOPECIA; ANEMIA; ARTICLE; BIOPSY; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FEBRILE NEUTROPENIA; FOLLOW UP; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MORTALITY; MUCOSA INFLAMMATION; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; NEUROTOXICITY; NEUTROPENIA; OVERALL SURVIVAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SQUAMOUS CELL CARCINOMA; THROMBOCYTOPENIA; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR GROWTH; VOMITING;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; DISEASE-FREE SURVIVAL; FLUOROURACIL; HEAD AND NECK NEOPLASMS; HUMANS; INFUSIONS, INTRAVENOUS; MIDDLE AGED; NEOPLASM INVASIVENESS; PROPORTIONAL HAZARDS MODELS; TEGAFUR; URACIL; VINBLASTINE;

EID: 43749092025     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-007-0599-0     Document Type: Article

References (34)

1. Vokes EE, Weichselbaum RR, Lippman S et al (1993) Head and neck cancer. N Engl J Med 328:184-194
2. The Department of Veterans Affairs Laryngeal Cancer Study Group (1991) Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 324:1685-1690
3. Spaulding MB, Fischer SG, Wolf GT et al (1994) Tumor response, toxicity and survival after neoadjuvant organ-preserving chemotherapy for advanced laryngeal carcinoma. J Clin Oncol 12:1592-1599
4. Lefebvre JL, Chevalier D, Luboinski B et al (1996) Larynx preservation in pyriform sinus cancer: preliminary results of a European organization for research and treatment of cancer phase III trial. J Natl Cancer Inst 88:890-899
5. Forastiere A, Berkey B, Maor M, et al (2001) Phase III trial to preserve the larynx: induction chemotherapy and radiotherapy versus concomitant chemoradiotherapy versus radiotherapy alone. Intergroup trial R91-11. Proceedings of ASCO 2001, 20:2a (abstract 4)
6. Forastiere A, Koch W, Trotti A et al (2001) Head and neck cancer. N Eng J Med 345:1890-1899
7. León X, López-Pousa A, de Vega M, Orús C, de Juan M, Quer M (2005) Results of an organ preservation protocol with induction chemotherapy and radiotherapy in patients with locally advanced laryngeal carcinoma. Eur Arch Otorhinolaryngol 262(2):93-98
8. Paccagnella A, Orlando A, Marchiori C et al (1994) Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: a study by the Grouppo di Studio sui Tumori della Testa e del Collo. J Natl Cancer Inst 86:265-272
9. Brizel D, Albers ME, Fisher S et al (1998) Hyperfraccionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 338:1798-1804
10. Merlano M, Vitale V, Rosso R et al (1992) Treatment of advanced squamous cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy. N Engl J Med 327:1115-1121
11. Wendt TG, Grabenbauer GG, Rödel CM et al (1998) Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study. J Clin Oncol 16:1318-1324
12. Kish JA, Weaver A, Jacobs J et al (1984) Cisplatin and 5-fluorouracil infusion in patients with recurrent and disseminated epidermoid cancer of the head and neck. Cancer 53:1819-1824
13. Vermorken JB, Remenar E, Van Herpen C, et al (2004) Standard cisplatin/infusional 5-fluorouracil (PF) vs docetaxel (T) plus PF (TPF) as neoadjuvant chemotherapy for nonresectable locally advanced squamous cell carcinoma of the head and neck (LA-SCCHN): a phase III trial of the EORTC Head and Neck Cancer Group (EORTC #24971). J Clin Oncol, 2004 ASCO annual meeting proceedings (post-meeting edition), vol 22, no 14S (July 15 Suppl), 5508
14. Posner MR (2006). Docetaxel added to induction therapy in head and neck cancer. Scientific special session, ASCO-2006
15. Calais G, Pointreau Y, Alfonsi M et al. (2006) Randomized phase III trial comparing induction chemotherapy using cisplatin (P) fluorouracil (F) with or without docetaxel (T) for organ preservation in hypopharynx and larynx cancer, preliminary results of GORTEC 2000-01. J Clin Oncol, 2006 ASCO annual meeting proceedings part I, vol 24, no. 18S (June 20 Suppl), 5506
16. Hitt R, López-Pousa A, Martínez-Trufero J et al (2005) Phase III study comparing cisplatin plus 5-fluorouracil to paclitaxel, cisplatin and 5-fluoruracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer. J Clin Oncol 23(34):8636-8645
17. Forastiere AA (2004) Is there a new role for induction chemotherapy in the treatment of head and neck cancer? J Natl Cancer Inst 96(22):1647-1649
18. Licitra L, Vermorken JB (2004) Is there still a role for neoadjuvant chemotherapy in head and neck cancer? Ann Oncol 15(1):7-11
19. Rinehart J, Ruff T, Cheung A, Hutchinson L, Tuggle R, Pinkston DR, Keville L, Wong L (2005) Neoadjuvant and concomitant chemotherapy and radiation therapy in patients with advanced head and neck carcinoma. Otolaryngol Head Neck Surg 132(1):69-74
20. Guadagnolo BA, Haddad RI, Posner MR, Weeks L, Wirth LJ, Norris CM, Sullivan CA, Goguen L, Busse PM, Tishler R (2005) Organ preservation and treatment toxicity with induction chemotherapy followed by radiation therapy or chemoradiation for advanced laryngeal cancer. Am J Clin Oncol 28(4):371-378
21. Gebbia V, Testa A, Valenza R et al (1993) A pilot study of vinorelbine on a weekly schedule in recurrent and/or metastatic squamous cell carcinoma of the head and neck. Eur J Cancer 29:1358-1359
22. Gebbia V, Maqntovani G, Agostara B et al (1995) Treatment of recurrent and/or metastatic squamous cell head and neck carcinoma with a combination of vinorelbine, cisplatin, and 5-fluorouracil: a multicenter phase II trial. Ann Oncol 6:987-991
23. Inuyama Y, Takeda C, Miyake H et al (1985) Phase II study of UFT for head and neck cancer. Jpn J Cancer Chemother 12(3):479-484
24. González-Larriba L, García-Carbonero I, Sastre-Valera J et al (1997) Neoadjuvant therapy with cisplatin/fluorouracil vs cisplatin /UFT in locally advanced squamous cell head and neck cancer. Oncology Septemeber (Suppl 10):90-97
25. Rivera F, Vega-Villegas ME, López-Brea MF et al (2004) Long-term results of a phase II trial of induction chemotherapy with uracil-ftegafur (UFT), vinorelbine and cisplatin (UFTVP) followed by radiotherapy concomitant with UFT and carboplatin (RT/UFTJ) in a primary site preservation setting for resectable locally advanced squamous cell carcinoma of larynx and hypopharynx. Laryngoscope 114(7):1163-1169
26. Pignon JP, Bourihis J, Domenge C et al (2000) Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analysis of updated individual data. MACH-NC Collaborative Group. Meta-analysis of chemotherapy on head and neck cancer. Lancet 355(9208):949-955
27. Forastiere AA, Goepfert H, Maor M et al (2003) Concomitant chemoradiotherapy, induction chemotherapy and radiotherapy for organ preservation in advanced larynx cancer. N Engl J Med 349(22):2091-2098
28. Posner MR, Lefebvre JL (2003) Docetaxel induction therapy in locally advanced squamous cell carcinoma of the head and neck. Br J Cancer 88(1):11-17
29. Haddad R, Colevas AD, Tishler R, Busse P, Goguen L, Sullivan C, Norris CM, Lake-Willcutt B, Case MA, Costello R, Posner M (2003) Docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck: the Dana Farber Cancer Institute experience. Cancer 97(2):412-418
30. Haddad R, Tishler RB, Norris CM, Mahadevan A, Busse P, Wirth L, Goguen LA, Sullivan CA, Costello R, Case MA, Posner MR (2003) Docetaxel, cisplatin, 5-fluorouracil (TPF)-based induction chemotherapy for head and neck cancer and the case for sequential, combined-modality treatment. Oncologist 8(1):35-44
31. Umeda M, Komatsubara H, Ojima Y, Minamikawa T, Shigeta T, Shibuya Y, Yokoo S, Komori T (2004) Lack of survival advantage in patients with advanced, resectable squamous cell carcinoma of the oral cavity receiving induction chemotherapy with cisplatin (CDDP), docetaxel (TXT) and 5-fluorouracil (5FU). Kobe J Med Sci 50(5-6):189-196
32. Mauer AM, Masters GA, Haraf DJ, Hoffman PC, Watson SM, Golomb HM, Vokes EE (1998) Phase I study of docetaxel with concomitant thoracic radiation therapy. J Clin Oncol 16(1):159-164
33. Tishler RB, Posner MR, Norris CM Jr, Mahadevan A, Sullivan C, Goguen L, Wirth LJ, Costello R, Case M, Stowell S, Sammartino D, Busse PM, Haddad RI (2006) Concurrent weekly docetaxel and concomitant boost radiation therapy in the treatment of locally advanced squamous cell cancer of the head and neck. Int J Radiat Oncol Biol Phys 65(4):1036-1044
34. Kramer NM, Horwitz EM, Cheng J, Ridge JA, Feigenberg SJ, Cohen RB, Nicolaou N, Sherman EJ, Babb JS, Damsker JA, Langer CJ (2005) Toxicity and outcome analysis of patients with recurrent head and neck cancer treated with hyperfractionated split-course reirradiation and concurrent cisplatin and paclitaxel chemotherapy from two prospective phase I and II studies. Head Neck 27(5):406-414